Safety, Reactogenicity and Immunogenicity of Two Quadrivalent Seasonal Influenza Vaccines (Fluzone(R) or Flublok(R)) With or Without One of Two Adjuvants (AF03 or Advax-CpG55.2) in Healthy Adults
Conditions: Influenza; Influenza Immunisation Interventions: Biological: Advax-CpG55.2; Drug: AF03; Biological: Influenza Virus Quadrivalent Inactivated Vaccine; Biological: Quadrivalent Recombinant Seasonal Influenza Vaccine Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Infectious Diseases | Influenza | Influenza Vaccine | Research | Vaccines